Privia Health Group (NASDAQ:PRVA) Price Target Raised to $30.00 at Needham & Company LLC

Privia Health Group (NASDAQ:PRVA) had its target price raised by Needham & Company LLC from $25.00 to $30.00 in a report released on Friday,Benzinga reports. They currently have a buy rating on the stock.

Other analysts have also recently issued reports about the company. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Truist Financial increased their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Barclays increased their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, Macquarie began coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target on the stock. One analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of “Buy” and a consensus target price of $26.59.

Privia Health Group Stock Down 1.9 %

Shares of Privia Health Group stock opened at $24.97 on Friday. The firm has a market cap of $3.00 billion, a P/E ratio of 249.72, a P/E/G ratio of 3.47 and a beta of 0.87. The business has a 50-day moving average price of $22.40 and a 200 day moving average price of $20.59. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. boosted its stake in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. bought a new position in Privia Health Group during the 4th quarter valued at $51,000. Quarry LP boosted its stake in Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares in the last quarter. Finally, KBC Group NV boosted its stake in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.